Serum prolidase enzyme activity and oxidative status in patients with fibromyalgia

References

• Ozgocmen S, Ozyurt H, Sogut S, Akyol O. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int 2006;26(7):585–97.
   PubMed Web of Science ®Google Scholar
• Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6–21.
   PubMedGoogle Scholar
• Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010;39(6):448–53.
   PubMed Web of Science ®Google Scholar
• Gronemann ST, Ribel-Madsen S, Bartels EM, Danneskiold-Samsoe B, Bliddal H. Collagen and muscle pathology in fibromyalgia patients. Rheumatology (Oxford) 2004;43(1):27–31.
   PubMed Web of Science ®Google Scholar
• Sprott H, Muller A, Heine H. Collagen crosslinks in fibromyalgia. Arthritis Rheum 1997;40(8):1450–4.
   PubMed Web of Science ®Google Scholar
• Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids 2008;35(4):731–8.
   PubMed Web of Science ®Google Scholar
• Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997;67(2):166–75.
   PubMed Web of Science ®Google Scholar
• Myara I, Wolfrom C, Charpentier C, Gautier M, Lemonnier A. Relationship between cell density and prolidase activity in human skin fibroblasts: effects of ascorbate and fructose. Biochimie 1984;66(6):445–9.
   PubMed Web of Science ®Google Scholar
• Altindag O, Celik H. Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 2006;11(3):131–5.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82(2):291–5.
   PubMed Web of Science ®Google Scholar
• Cordero MD. Oxidative stress in fibromyalgia: pathophysiology and clinical implications. Reumatol Clin 2011;7(5):281–3.
   PubMedGoogle Scholar
• Miyamae T, Seki M, Naga T, Uchino S, Asazuma H, Yoshida T, et al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep 2013;18(1):12–19.
   PubMed Web of Science ®Google Scholar
• Tsou PS, Talia NN, Pinney AJ, Kendzicky A, Piera-Velazquez S, Jimenez SA, et al. Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts. Arthritis Rheum 2012;64(6):1978–89.
   PubMedGoogle Scholar
• Yamamoto T. Autoimmune mechanisms of scleroderma and a role of oxidative stress. Self Nonself 2011;2(1):4–10.
   PubMedGoogle Scholar
• Akkus S, Naziroglu M, Eris S, Yalman K, Yilmaz N, Yener M. Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Funct 2009;27(4):181–5.
   PubMed Web of Science ®Google Scholar
• Cordero MD, de Miguel M, Moreno-Fernandez AM. Mitochondrial dysfunction in fibromyalgia and its implication in the pathogenesis of disease. Med Clin (Barc) 2011;136(6):252–6.
   PubMed Web of Science ®Google Scholar
• Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep 2004;8(5):369–78.
   PubMedGoogle Scholar
• Neyal M, Yimenicioglu F, Aydeniz A, Taskin A, Saglam S, Cekmen M, et al. Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 2013;115(6):736–40.
   PubMed Web of Science ®Google Scholar
• Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18(5):728–33.
   PubMed Web of Science ®Google Scholar
• Armutlu K, Keser I, Korkmaz N, Akbiyik DI, Sumbuloglu V, Guney Z, et al. Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients. J Neurol Sci 2007;255(1–2):64–8.
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46(10):1121–3.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112–9.
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103–11.
   PubMed Web of Science ®Google Scholar
• Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005;5:95.
   PubMed Web of Science ®Google Scholar
• Aslan M, Sabuncu T, Kocyigit A, Celik H, Selek S. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2007;17(10):734–40.
   PubMed Web of Science ®Google Scholar
• Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta 1982;125(2):193–205.
   PubMed Web of Science ®Google Scholar
• Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem 1952;199(1):91–5.
   PubMed Web of Science ®Google Scholar
• Eckerson HW, Romson J, Wyte C, La Du BN. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1983;35(2):214–27.
   PubMed Web of Science ®Google Scholar
• Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30(2):211–15.
   PubMed Web of Science ®Google Scholar
• Karna E, Surazynski A, Palka J. Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. Int J Exp Pathol 2000;81(5):341–7.
   PubMed Web of Science ®Google Scholar
• Wolanska M, Sobolewski K, Drozdzewicz M. Integrins and prolidase activity in uterine leiomyoma during tumor growth. Ginekol Pol 2001;72(3):121–6.
   PubMedGoogle Scholar
• Wolczynski S, Surazynski A, Swiatecka J, Palka J. Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells. Gynecol Endocrinol 2001;15(3):225–33.
   PubMed Web of Science ®Google Scholar
• Deberg M, Labasse A, Christgau S, Cloos P, Bang Henriksen D, Chapelle JP, et al. New serum biochemical markers (Coll 2–1 and Coll 2–1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2005;13(3):258–65.
   PubMed Web of Science ®Google Scholar
• Duong HS, Zhang QZ, Le AD, Kelly AP, Kamdar R, Messadi DV. Elevated prolidase activity in keloids: correlation with type I collagen turnover. Br J Dermatol 2006;154:820–8.
   PubMed Web of Science ®Google Scholar
• Hilali N, Vural M, Camuzcuoglu H, Camuzcuoglu A, Aksoy N. Increased prolidase activity and oxidative stress in PCOS. Clin Endocrinol (Oxf) 2013;79(1):105–10.
   PubMed Web of Science ®Google Scholar
• Gencer M, Aksoy N, Dagli EC, Uzer E, Aksoy S, Selek S, et al. Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease. J Clin Lab Anal 2011;25(1):8–13.
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, Ste-Marie PA, Pereira JX. Canadian Fibromyalgia Guidelines C. Fibromyalgia: evolving concepts over the past 2 decades. CMAJ 2013;17(185):E645–51.
   Google Scholar
• Cakmak A, Soker M, Koc A, Erel O. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major. J Pediatr Hematol Oncol 2009;31(8):583–7.
   PubMed Web of Science ®Google Scholar
• Borba EF, Borges CT, Bonfa E. Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 2005;25(5):379–83.
   PubMed Web of Science ®Google Scholar
• Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21(4):473–80.
   PubMed Web of Science ®Google Scholar
• Malin R, Jarvinen O, Sisto T, Koivula T, Lehtimaki T. Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis. Atherosclerosis 2001;157(2):301–7.
   PubMed Web of Science ®Google Scholar
• Altindag O, Gur A, Calgan N, Soran N, Celik H, Selek S. Paraoxonase and arylesterase activities in fibromyalgia. Redox Rep 2007;12(3):134–8.
   PubMed Web of Science ®Google Scholar
• Cordero MD, Diaz-Parrado E, Carrion AM, Alfonsi S, Sanchez-Alcazar JA, Bullon P, et al. Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid Redox Signal 2013;18(7):800–7.
   PubMed Web of Science ®Google Scholar
• Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxf) 2001;40(7):743–9.
   PubMed Web of Science ®Google Scholar
• Cordero MD, Alcocer-Gomez E, Cano-Garcia FJ, De Miguel M, Carrion AM, Navas P, et al. Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 2011;6(10):e26915.
   PubMedGoogle Scholar